DENV-specific IgA contributes protective and non-pathologic function during antibody-dependent enhancement of DENV infection.

Dengue represents a growing public health burden worldwide, accounting for approximately 100 million symptomatic cases and tens of thousands of fatalities yearly. Prior infection with one serotype of dengue virus (DENV) is the greatest known risk factor for severe disease upon secondary infection wi...

Full description

Bibliographic Details
Published in:	PLoS Pathogens
Main Authors:	Adam D Wegman, Mitchell J Waldran, Lauren E Bahr, Joseph Q Lu, Kristen E Baxter, Stephen J Thomas, Adam T Waickman
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-08-01
Online Access:	https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1011616&type=printable

Similar Items

Conventional and antibody-enhanced DENV infection of human macrophages induces differential immunotranscriptomic profiles
by: Céline S. C. Hardy, et al.
Published: (2025-03-01)

Anti-DENV-ED3 antibody cross-talks generate immune interference among the four DENVs
by: Md. Din Islam, et al.
Published: (2024-12-01)

Mapping IgA Epitope and Cross-Reactivity between Severe Acute Respiratory Syndrome-Associated Coronavirus 2 and DENV
by: Salvatore G. De-Simone, et al.
Published: (2023-11-01)

Recent Advances in DENV Receptors
by: Shuyu Fang, et al.
Published: (2013-01-01)

Retracted: Recent Advances in DENV Receptors
by: The Scientific World Journal
Published: (2013-01-01)

基于ＤＥＮＶ－ｐｒＭ／Ｅ基因构建ＤＥＮＶ－ＶＬＰ及其免疫学特性
Published: (2014-01-01)

Comparative monocyte and T cell responses in DENV-exposed subjects from South-East Asia and DENV-naïve residents in Taiwan
by: Sheng-Hsuan Wang, et al.
Published: (2025-02-01)

Detection of Anti-ZIKV NS1 IgA, IgM, and Combined IgA/IgM and Identification of IL-4 and IL-10 as Potential Biomarkers for Early ZIKV and DENV Infections in Hyperendemic Regions, Thailand
by: Vajee Petphong, et al.
Published: (2023-05-01)

Global Dynamics of Secondary DENV Infection with Diffusion
by: A. M. Elaiw, et al.
Published: (2021-01-01)

Q63, a novel DENV2 RdRp non-nucleoside inhibitor, inhibited DENV2 replication and infection
by: Xingang Yao, et al.
Published: (2018-12-01)

Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naïve and DENV-Exposed Individuals in a Brazilian Cohort
by: Cássia G. T. Silveira, et al.
Published: (2022-06-01)

A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity
by: Ellen Young, et al.
Published: (2023-03-01)

Host immune response against DENV and ZIKV infections
by: Shamala Devi Sekaran, et al.
Published: (2022-09-01)

Dengue in Fiji: epidemiology of the 2014 DENV-3 outbreak
by: Aneley Getahun S, et al.
Published: (2019-07-01)

Correction: An Explosive Epidemic of DENV-3 in Cairns, Australia
Published: (2013-01-01)

Correction: An Explosive Epidemic of DENV-3 in Cairns, Australia
Published: (2014-01-01)

Retrospective Study of Arbovirus Circulation in Northeast Brazil in 2019 and 2022: Insights into the Re-Emergence of DENV-3 and the Co-Infection of DENV-1 and CHIKV
by: Sêmilly Suélen da Silva Sousa, et al.
Published: (2025-03-01)

Identification of Differentially Expressed Genes in BALB/c Mouse Liver upon Primary Infection with DENV1 and Sequential Heterologous Infection with DENV2
by: Indeevari A. C. Wickremsinghe, et al.
Published: (2018-10-01)

Nationwide Distribution of Dengue Virus Type 3 (DENV-3) Genotype I and Emergence of DENV-3 Genotype III during the 2019 Outbreak in Bangladesh
by: Snigdha Rahman Titir, et al.
Published: (2021-04-01)

Systematic mutational analysis of epitope-grafted ED3 immunogenicity reveals a DENV3-DENV4 bi-serospecific ED3 mutant
by: Mamtaz Sultana, et al.
Published: (2022-01-01)

Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope.
by: S Kyle Austin, et al.
Published: (2012-01-01)

Construction and Rescue of a DNA-Launched DENV2 Infectious Clone
by: Madeline Holliday, et al.
Published: (2023-01-01)

Mouse models as a tool to study asymptomatic DENV infections
by: Paulo Henriques, et al.
Published: (2025-03-01)

Predominance of DENV-3 among patients in Ouagadougou, Burkina Faso
by: Abdoul Karim Ouattara, et al.
Published: (2025-01-01)

Phylogeography of recently emerged DENV-2 in southern Viet Nam.
by: Maia A Rabaa, et al.
Published: (2010-07-01)

The Molecular Interactions of ZIKV and DENV with the Type-I IFN Response
by: Rosa C. Coldbeck-Shackley, et al.
Published: (2020-09-01)

DENV and SARS-CoV-2 and their coexistence in an endemic area
by: Imelda Menchaca-Armenta, et al.
Published: (2024-01-01)

DENV-3 precursor membrane (prM) glycoprotein enhances E protein immunogenicity and confers protection against DENV-2 infections in a murine model
by: Roberto S. Dias, et al.
Published: (2021-05-01)

Emergence of a Novel Dengue Virus 3 (DENV-3) Genotype-I Coincident with Increased DENV-3 Cases in Yangon, Myanmar between 2017 and 2019
by: Aung Min Soe, et al.
Published: (2021-06-01)

Temporally integrated single cell RNA sequencing analysis of PBMC from experimental and natural primary human DENV-1 infections.
by: Adam T Waickman, et al.
Published: (2021-01-01)

Evolution of a functionally intact but antigenically distinct DENV fusion loop
by: Rita M Meganck, et al.
Published: (2023-09-01)

Balance of neutralizing Antibodies and Antibody Dependent Enhancement (ADE) In Dengue Virus (DENV) infection: a literature review
by: Regita Aulia Rosalina, et al.
Published: (2024-12-01)

Attrition in serum anti-DENV antibodies correlates with high anti-SARS-CoV-2 IgG levels and low DENV positivity in mosquito vectors-Findings from a state-wide cluster-randomized community-based study in Tamil Nadu, India.
by: Sivaprakasam T Selvavinayagam, et al.
Published: (2024-01-01)

Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses.
by: Stefan W Metz, et al.
Published: (2016-10-01)

Correction: Attrition in serum anti-DENV antibodies correlates with high anti-SARS-CoV-2 IgG levels and low DENV positivity in mosquito vectors-Findings from a state-wide cluster-randomized community-based study in Tamil Nadu, India.
by: Sivaprakasam T Selvavinayagam, et al.
Published: (2024-01-01)

Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse.
by: Naphak Modhiran, et al.
Published: (2010-12-01)

Dual-fluorescent reporter for live-cell imaging of the ER during DENV infection
by: Lochlain Corliss, et al.
Published: (2022-10-01)

Ultrapotent human antibodies lock E protein dimers central region of diverse DENV3 morphological variants
by: Guntur Fibriansah, et al.
Published: (2025-10-01)

Flying under the radar – impact and factors influencing asymptomatic DENV infections
by: Paulo Henriques, et al.
Published: (2023-11-01)

Galectin-1 exerts inhibitory effects during DENV-1 infection.
by: Karina Alves Toledo, et al.
Published: (2014-01-01)